Meeder Asset Management’s Voyager Therapeutics VYGR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-157
| Closed | – | – | 2336 |
|
|
2021
Q3 | $0 | Sell |
157
-1
| -0.6% | – | ﹤0.01% | 2655 |
|
|
2021
Q2 | $1K | Buy |
+158
| New | +$1K | ﹤0.01% | 2407 |
|
|
2020
Q2 | – | Sell |
-646
| Closed | -$6K | – | 2502 |
|
|
2020
Q1 | $6K | Buy |
646
+473
| +273% | +$4.39K | ﹤0.01% | 1733 |
|
|
2019
Q4 | $2K | Sell |
173
-6,485
| -97% | -$75K | ﹤0.01% | 2070 |
|
|
2019
Q3 | $114K | Sell |
6,658
-824
| -11% | -$14.1K | 0.01% | 763 |
|
|
2019
Q2 | $204K | Buy |
7,482
+7,180
| +2,377% | +$196K | 0.01% | 576 |
|
|
2019
Q1 | $6K | Buy |
302
+31
| +11% | +$616 | ﹤0.01% | 1372 |
|
|
2018
Q4 | $3K | Sell |
271
-11
| -4% | -$122 | ﹤0.01% | 1529 |
|
|
2018
Q3 | $5K | Buy |
+282
| New | +$5K | ﹤0.01% | 1341 |
|
|
2018
Q2 | – | Sell |
-243
| Closed | -$6K | – | 1693 |
|
|
2018
Q1 | $6K | Buy |
243
+69
| +40% | +$1.7K | ﹤0.01% | 1193 |
|
|
2017
Q4 | $2K | Buy |
174
+126
| +263% | +$1.45K | ﹤0.01% | 1511 |
|
|
2017
Q3 | $1K | Sell |
48
-146
| -75% | -$3.04K | ﹤0.01% | 1570 |
|
|
2017
Q2 | $2K | Buy |
194
+42
| +28% | +$433 | ﹤0.01% | 1434 |
|
|
2017
Q1 | $2K | Buy |
152
+141
| +1,282% | +$1.86K | ﹤0.01% | 1413 |
|
|
2016
Q4 | $0 | Buy |
+11
| New | – | ﹤0.01% | 1065 |
|